BRIEF published on 03/25/2024 at 17:35, 1 year 8 months ago SURTECO GROUP SE Reports Preliminary Results for 2023 EBITDA Financial Performance Preliminary Results SURTECO Omnova Acquisition
PRESS RELEASE published on 03/25/2024 at 17:30, 1 year 8 months ago SURTECO GROUP SE: Preliminary result for the business year 2023 SURTECO GROUP SE reported unaudited preliminary results for the business year 2023, including a consolidated net profit of €835.1 million. Despite challenges, the company achieved adjusted EBITDA of €86.4 million EBITDA Financial Performance Preliminary Results Business Year 2023 SURTECO GROUP SE
PRESS RELEASE published on 11/09/2023 at 14:00, 2 years ago New management of Corporate Communications and Marketing
PRESS RELEASE published on 10/27/2023 at 07:30, 2 years 1 month ago SURTECO GROUP SE: Sales above year-earlier value on the back of Omnova acquisition; one-off effects depress earnings
PRESS RELEASE published on 10/16/2023 at 18:24, 2 years 1 month ago EQS-Adhoc: SURTECO GROUP SE: Adjustment of the forecast for 2023
PRESS RELEASE published on 07/31/2023 at 07:30, 2 years 4 months ago SURTECO GROUP SE: Sales up compared with previous year on the back of Omnova integration; Ongoing weak demand and one-off exceptional effects impact negatively on earnings
PRESS RELEASE published on 07/20/2023 at 19:59, 2 years 4 months ago EQS-Adhoc: SURTECO GROUP SE: Adjustment of the forecast for 2023 due to one-off special effects and continued weak demand
PRESS RELEASE published on 06/07/2023 at 17:01, 2 years 5 months ago SURTECO GROUP SE: Annual General Meeting passes resolution to pay dividend of € 0.70 per share; Premature renewed appointment of Mr Wolfgang Moyses as Chairman of the Management Board
PRESS RELEASE published on 06/07/2023 at 16:55, 2 years 5 months ago EQS-Adhoc: SURTECO GROUP SE: Premature renewed appointment of Mr Wolfgang Moyses as Chairman of the Management Board
PRESS RELEASE published on 04/28/2023 at 07:00, 2 years 7 months ago SURTECO GROUP SE: Sales of € 205.7 million in the first quarter. EBIT at € 7.6 million down 62 % on previous year owing to one-off acquisition costs and temporarily higher expenses.
Published on 12/05/2025 at 02:35, 3 hours 52 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 27 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 22 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 27 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 36 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 12 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 27 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 42 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 43 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 26 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
